We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1326
Madrigal Pharmaceuticals
MDGL
$12.6B
-656
Closed -$77K
MGNX icon
1327
MacroGenics
MGNX
$235M
-2,627
Closed -$84K
MNKD icon
1328
MannKind Corp
MNKD
$1.28B
-19,748
Closed -$77K
MODV
1329
DELISTED
ModivCare
MODV
-24,832
Closed -$3.68M
MRSN
1330
DELISTED
Mersana Therapeutics
MRSN
-173
Closed -$70K
MYGN icon
1331
Myriad Genetics
MYGN
$530M
-2,510
Closed -$76K
NGNE icon
1332
Neurogene
NGNE
$696M
-81
Closed -$20K
NKTX icon
1333
Nkarta
NKTX
$162M
-1,429
Closed -$47K
NRIX icon
1334
Nurix Therapeutics
NRIX
$2.43B
-1,581
Closed -$49K
NSIT icon
1335
Insight Enterprises
NSIT
$3.55B
-37,581
Closed -$3.59M
NTLA icon
1336
Intellia Therapeutics
NTLA
$1.5B
-1,189
Closed -$95K
NTRA icon
1337
Natera
NTRA
$37.5B
-744
Closed -$76K
NVAX icon
1338
Novavax
NVAX
$1.23B
-380
Closed -$69K
OCGN icon
1339
Ocugen
OCGN
$410M
-7,800
Closed -$53K
OI icon
1340
O-I Glass
OI
$1.39B
-16,791
Closed -$247K
OPK icon
1341
Opko Health
OPK
$921M
-17,566
Closed -$75K
ORIC icon
1342
Oric Pharmaceuticals
ORIC
$1.25B
-1,572
Closed -$39K
PASG icon
1343
Passage Bio
PASG
$15.9M
-106
Closed -$37K
PBYI icon
1344
Puma Biotechnology
PBYI
$406M
-2,837
Closed -$28K
PCVX icon
1345
Vaxcyte
PCVX
$7.89B
-2,122
Closed -$42K
PGEN icon
1346
Precigen
PGEN
$1.93B
-8,708
Closed -$60K
PLAB icon
1347
Photronics
PLAB
$1.79B
-58,534
Closed -$753K
PMVP icon
1348
PMV Pharmaceuticals
PMVP
$66.1M
-614
Closed -$20K
PRAX icon
1349
Praxis Precision Medicines
PRAX
$9.07B
-58
Closed -$29K
PRLD icon
1350
Prelude Therapeutics
PRLD
$305M
-1,126
Closed -$49K

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.